Last updated on February 2019

A Study to Evaluate the Efficacy Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression


Brief description of study

The purpose of this study is to evaluate the efficacy of fixed dosed intranasal esketamine compared to intranasal placebo, as an add-on to an oral antidepressant in Japanese participants with treatment-resistant depression (TRD), in improving depressive symptoms.

Clinical Study Identifier: NCT02918318

Contact Investigators or Research Sites near you

Start Over

Use link at the bottom ...

Shinseikai Kaku Mental Clinic
Fukuoka-Shi, Japan
0.73miles
  Connect »

Use link at the bottom ...

Ange Psychiatric Clinic
Fukuoka, Japan
1.92miles
  Connect »

Use link at the bottom ...

Fukuoka University Hospital
Fukuoka, Japan
3.44miles
  Connect »

Use link at the bottom ...

Kuramitsu Hospital
Fukuoka, Japan
6.32miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.